IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Supriya Lifescience IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 700.00 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. Axis Capital , ICICI Securities are the merchant bankers of Supriya Lifescience IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 15th May 2021.
Supriya Lifescience IPO open date is 16th December 2021 and close date is 20th December 2021. IPO Allotment Date is 23rd December 2021 and Listing date is 28th December 2021.
IPO
Size:
₹ 700.00 Cr.
Avg IPO Size (Sector Based)
: ₹
1,431.30 cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
Axis Capital
IPO by BRLM so far:
163
City:
Mumbai
IPO so far:
189
Revenue (annualised):
₹
460.12
cr. 
PE
Ratio:
17.80x
Average Sector PE Ratio: 27.10x
Supriya Lifescience IPO size is ₹ 700.00 Cr. with IPO price of ₹ 274.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Axis Capital Limited is the book-running lead manager of the Supriya Lifescience IPO. Link Intime India Private Limited is the Registrar for Supriya Lifescience IPO.
Supriya Lifescience IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Supriya Lifescience IPO, based in Mumbai, operates in the Pharmaceutical sector with a focus on manufacturers and suppliers of active pharmaceuticals. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Supriya Lifescience IPO size is ₹ 700.00 Cr. with fresh issue size of ₹ 700 and Offer for sale being ₹ Nil
The IPO allotment date for Supriya Lifescience IPO is expected to be 23rd December 2021, after the finalization of basis of allotment. Investors can check Supriya Lifescience IPO allotment status on the registrars website, Link Intime India Private Limited . Supriya Lifescience IPO refund dates are 24th December 2021.
Supriya Lifescience IPO is expected to be listed on 28th December 2021.
The upper price band for the Supriya Lifescience IPO is set at ₹ 274.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Supriya Lifescience IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Supriya Lifescience IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 20th December 2021. After submission, funds are blocked until the basis of allotment of Supriya Lifescience IPO is finalised.
The merchant banker for Supriya Lifescience IPO is Axis Capital Limited , ICICI Securities Limited . Axis Capital Limited , ICICI Securities Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Supriya Lifescience IPO RHP for further details.
The registrar for Supriya Lifescience IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Supriya Lifescience IPO through their official website or helpline.
Supriya Lifescience IPO was subscribed 71.51 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 700.00 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,431.30 Cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
Axis Capital
IPO by BRLM so far:
163
City:
Mumbai
IPO so far:
189
Revenue (annualised):
₹ 449.60 cr.
PE
Ratio:
17.80x
Average Sector PE Ratio: 27.10x
Supriya Lifescience IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Supriya Lifescience Financial Review Page
Merchant Banker(s) of Supriya Lifescience IPO: Axis Capital Limited , ICICI Securities Limited
Supriya Lifescience IPO subscription was 71.51 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Supriya Lifescience IPO listed at a listing price of 390.35 against the offer price of 274.00.
The current market price of Supriya Lifescience is 711.30.
Why Us?
